Senate Democrats say they plan to challenge a ruling by the MP who submitted a proposal sponsored by Senator Raphael Warnock (D-Ga.) to cut insulin prices under the Inflation Reduction Act, according to a Democrat who is familiar with the plan.
As of now, Warnock’s proposal to limit its own insulin costs to $35 a month is in the bill, but the MP is expected to rule on the Senate floor that it does not comply with the Byrd rule, which prohibits policy making in budget reconciliation bills that have a tangential impact on expenses and revenues.
But Democrats plan to challenge the MP’s ruling on the floor, meaning they need 60 votes to waive an objection to keeping the insulin supply in law.
Any attempt to overthrow the MP probably won’t get 10 Republican votes, but it will make Republicans known as opponents of a $35 monthly cap on patients’ insulin costs, which Democrats can use as political ammunition at the midterm. elections.
“I think it’s hard for elected officials to go home like everyone else is doing now and try to explain, if they choose to vote that way, why they don’t support getting aid to millions. Americans being crushed by these insulin bills,” Ron Wyden (D-Ore.), chairman of the Senate Finance Committee, said before the showdown on the floor.
Maine Sen. Susan Collins (R) said it was “unfortunate” that the Democrats turned the issue into a political football.
Collins has sponsored a bipartisan bill with Sen. Jeanne Shaheen (DN.H.) to reduce insulin costs.
Their bill would encourage insulin manufacturers to lower their list prices and limit out-of-pocket costs for patients with diabetes by allowing group and individual health plans on the market to waive deductibles and cost-sharing to no more than $35 per month, according to a report. summary provided by their offices.
“I’m sorry it’s been included” in the reconciliation package, Collins said of the insulin proposal expected to be slated to the floor on Saturday.
Mychael Schnell contributed.